Expanded Access for Relatlimab


Study First Submitted Date 2021-11-17
Study First Posted Date 2021-12-28
Last Update Posted Date 2022-04-28
Verification Month Year April 2022
Verification Date 2022-04-30
Last Update Posted Date 2022-04-28

Browse Interventions

Sequence: 95905360 Sequence: 95905361 Sequence: 95905362 Sequence: 95905363 Sequence: 95905364
Mesh Term Relatlimab Mesh Term Antineoplastic Agents, Immunological Mesh Term Antineoplastic Agents Mesh Term Immune Checkpoint Inhibitors Mesh Term Molecular Mechanisms of Pharmacological Action
Downcase Mesh Term relatlimab Downcase Mesh Term antineoplastic agents, immunological Downcase Mesh Term antineoplastic agents Downcase Mesh Term immune checkpoint inhibitors Downcase Mesh Term molecular mechanisms of pharmacological action
Mesh Type mesh-list Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor

Id Information

Sequence: 40101204
Id Source org_study_id
Id Value CA209-64R


Sequence: 42503601 Sequence: 42503602 Sequence: 42503603 Sequence: 42503604 Sequence: 42503605
Name Australia Name Czechia Name France Name Singapore Name United States
Removed True Removed True Removed True Removed True Removed True


Sequence: 52412050
Intervention Type Drug
Name Relatlimab


Sequence: 48252202
Agency Class INDUSTRY
Lead Or Collaborator lead
Name Bristol-Myers Squibb

Overall Officials

Sequence: 29243310
Role Study Director
Name Bristol-Myers Squibb
Affiliation Bristol-Myers Squibb


Sequence: 30723470
Minimum Age N/A
Maximum Age N/A
Adult True
Child True
Older Adult True

Calculated Values

Sequence: 253969308
Registered In Calendar Year 2021
Were Results Reported False
Has Single Facility False


Sequence: 4381454 Sequence: 4381455 Sequence: 4381456 Sequence: 4381457
Url https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html Url https://www.bmsstudyconnect.com/s/US/English/USenHome Url https://www.bms.com/healthcare-providers/early-patient-access-to-investigational-medicine/investigational-drugs-available.html Url https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm
Description BMS Clinical Trial Information Description BMS Clinical Trial Patient Recruiting Description Pre-approval Access (PAA) Healthcare Practitioner Requests Description FDA Safety Alerts and Recalls

Responsible Parties

Sequence: 28836388
Responsible Party Type Sponsor